- Home
- BY vs RLAY Comparison
BY vs RLAY Comparison
Compare BY & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BY
- RLAY
- Stock Information
- Founded
- BY 1914
- RLAY 2015
- Country
- BY United States
- RLAY United States
- Employees
- BY N/A
- RLAY N/A
- Industry
- BY Major Banks
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BY Finance
- RLAY Health Care
- Exchange
- BY Nasdaq
- RLAY Nasdaq
- Market Cap
- BY 1.2B
- RLAY 1.1B
- IPO Year
- BY 2017
- RLAY 2020
- Fundamental
- Price
- BY $30.94
- RLAY $4.48
- Analyst Decision
- BY Hold
- RLAY Strong Buy
- Analyst Count
- BY 3
- RLAY 10
- Target Price
- BY $32.00
- RLAY $20.11
- AVG Volume (30 Days)
- BY 108.2K
- RLAY 2.6M
- Earning Date
- BY 01-23-2025
- RLAY 11-06-2024
- Dividend Yield
- BY 1.17%
- RLAY N/A
- EPS Growth
- BY 6.38
- RLAY N/A
- EPS
- BY 2.76
- RLAY N/A
- Revenue
- BY $373,634,000.00
- RLAY $10,006,000.00
- Revenue This Year
- BY N/A
- RLAY N/A
- Revenue Next Year
- BY $3.24
- RLAY N/A
- P/E Ratio
- BY $11.33
- RLAY N/A
- Revenue Growth
- BY 9.77
- RLAY N/A
- 52 Week Low
- BY $19.70
- RLAY $4.25
- 52 Week High
- BY $32.89
- RLAY $12.14
- Technical
- Relative Strength Index (RSI)
- BY 51.44
- RLAY 39.07
- Support Level
- BY $30.56
- RLAY $4.41
- Resistance Level
- BY $31.48
- RLAY $5.03
- Average True Range (ATR)
- BY 0.58
- RLAY 0.31
- MACD
- BY -0.21
- RLAY 0.05
- Stochastic Oscillator
- BY 22.15
- RLAY 20.65
About BY Byline Bancorp Inc.
Byline Bancorp Inc is the holding company for Byline Bank, a full-service commercial bank serving small-and-medium-sized businesses, financial sponsors, and consumers. The company offers a broad range of banking products and services to small and medium sized businesses, commercial real estate and online account opening to consumer and business. Also provide trust and wealth management services to our customers. In addition to traditional commercial banking business, company provide small ticket equipment leasing solutions through Byline Financial Group, a wholly-owned subsidiary of Byline Bank.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).